References

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021.

10.1093/neuonc/noae145 · 2024 · External reference

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

10.1093/neuonc/noab106 · 2021 · External reference

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma.

10.1056/nejmoa043330 · 2005 · External reference

Strategies increasing the effectiveness of temozolomide at various levels of anti-GBL therapy.

10.1016/j.biopha.2023.115174 · 2023 · External reference

Circulating biomarkers in patients with glioblastoma.

10.1038/s41416-019-0603-6 · 2020 · External reference

MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.

10.1016/j.critrevonc.2017.10.003 · 2017 · External reference

MicroRNAs: genomics, biogenesis, mechanism, and function.

10.1016/s0092-8674(04)00045-5 · 2004 · External reference

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.

10.1002/emmm.201100209 · 2012 · External reference

Circulating microRNAs as stable blood-based markers for cancer detection.

10.1073/pnas.0804549105 · 2008 · External reference

Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.

10.1093/neuonc/nou169 · 2015 · External reference

Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.

10.1007/s12035-014-9079-9 · 2016 · External reference

Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo.

10.3892/ijo_00000296 · 2009 · External reference

Serum microRNA profiling in patients with glioblastoma: a survival analysis.

10.1186/s12943-017-0628-5 · 2017 · External reference

Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature.

10.3390/ijms21197211 · 2020 · External reference

MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells.

10.1016/j.bbrc.2008.12.169 · 2009 · External reference

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

10.1136/bmj.n71 · 2021 · External reference

Evaluation of the quality of prognosis studies in systematic reviews.

10.7326/0003-4819-144-6-200603210-00010 · 2006 · External reference

A guide to systematic review and meta-analysis of prognostic factor studies.

10.1136/bmj.k4597 · 2019 · External reference

Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.

10.1007/s11060-019-03256-2 · 2019 · External reference

Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis.

10.1007/s12031-020-01706-5 · 2021 · External reference

PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis.

10.1002/cl2.1230 · External reference

MicroRNAs 221 and 222 bypass quiescence and compromise cell survival.

10.1158/0008-5472.can-07-6754 · 2008 · External reference

miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors.

10.1007/s11060-009-9797-4 · 2009 · External reference

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.

10.1186/1476-4598-9-229 · 2010 · External reference

Regulation of p27Kip1 by miRNA 221/222 in Glioblastoma.

10.4161/cc.6.16.4526 · 2007 · External reference

miR-221/222 promote malignant progression of glioma through activation of the Akt pathway.

10.3892/ijo_00000570 · 2010 · External reference

miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ.

10.1038/onc.2011.280 · 2012 · External reference

miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.

10.1111/1759-7714.13382 · 2020 · External reference

miR-221-3p and miR-15b-5p promote cell proliferation and invasion by targeting Axin2 in liver cancer.

10.3892/ol.2019.11056 · 2019 · External reference

Pharmacological WNT Inhibition Reduces Proliferation, Survival and Clonogenicity of Glioblastoma Cells.

10.1097/nen.0000000000000227 · 2015 · External reference

MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.

10.18632/oncotarget.5323 · 2015 · External reference

Data Extraction of Serum and Plasma MicroRNA-15b and MicroRNA-221 as Prognostic Biomarkers in Adult Glioma: A Systematic Review.

10.6084/m9.figshare.33826714 · External reference

QUIPS Risk of Bias for included studies from Serum and Plasma MicroRNA-15b and MicroRNA-221 as Prognostic Biomarkers in Adult Glioma: A Systematic Review.

10.6084/m9.figshare.33826699 · External reference

PRISMA Flow Diagram and PRISMA Guideline Checklist.

10.6084/m9.figshare.33383926 · External reference